Table 3.
1-year postoperative comorbidity remission by age
| < 45 years old | 45 – 69 years old | ≥70 years old | ||||
|---|---|---|---|---|---|---|
| Rate (%) |
ORa | Rate (%) |
OR | Rate (%) |
OR | |
| Roux-en-Y Gastric Bypass | ||||||
| Diabetes: Oral medications (N= 3149) |
85.3 | 1.63* (1.28, 2.07) | 80.1 | Ref. | 90.9 | 1.20 (0.56, 2.57) |
| Diabetes: Insulin (N=1590) |
75.0 | 1.25 (0.93, 1.69) | 71.6 | Ref. | 67.0 | 0.76 (0.38, 1.53) |
| Obstructive Sleep Apnea (N=3523) |
72.9 | 1.90* (1.59, 2.26) | 62.4 | Ref. | 51.6 | 0.59 (0.32, 1.07) |
| Hyperlipidemia (N=3627) |
77.3 | 2.04* (1.64, 2.53) | 67.8 | Ref. | 63.3 | 0.68 (0.40, 1.17) |
| Hypertension (N=5490) |
68.9 | 2.23* (1.94, 2.56) | 53.6 | Ref. | 45.7 | 0.59* (0.37, 0.93) |
| Sleeve Gastrectomy | ||||||
| Diabetes (oral medications) (N=3868) |
82.0 | 1.62* (1.32, 1.99) | 76.9 | Ref. | 74.1 | 0.75 (0.47, 1.20) |
| Diabetes (insulin) (N=1480) |
67.2 | 1.40* (1.04, 1.88) | 61.9 | Ref. | 67.9 | 0.84 (0.46, 1.53) |
| Obstructive Sleep Apnea (N=5467) |
63.4 | 1.86* (1.63, 2.12) | 51.8 | Ref. | 48.6 | 0.83 (0.55, 1.24) |
| Hyperlipidemia (N=4639) |
63.2 | 1.89* (1.61, 2.23) | 52.0 | Ref. | 42.4 | 0.68 (0.46, 1.01) |
| Hypertension (N=8106) |
64.3 | 2.03* (1.82, 2.27) | 50.4 | Ref. | 43.4 | 0.69* (0.50, 0.95) |
*
p <0.05 compared with risk-adjusted complication rate of patients age 45–69 years old,
a
OR; odds ratio